George Kemble is the Executive Chairman of Sagimet Biosciences, a biotechnology company developing therapies for inflammatory and fibrotic diseases.
George Kemble is the Executive Chairman of Sagimet Biosciences, a biotechnology company developing therapies for inflammatory and fibrotic diseases. He was previously in leadership positions at 3V Biotherapeutics. Kemble is an active board member and shareholder, having sold shares in late 2025.
Full founder directory · Investor directory · Company funding database · Fundraising library